Evidence map›Paper›PMID 39739706›Full record

ArticlePloS one2024

Interrater reliability and agreement of the NEUMOBACT checklist about infection-prevention performance of intensive care nurses in simulation-based scenarios.

Marta Raurell-Torredà, Ignacio Zaragoza-García, Oscar Arrogante, Anna María Aliberch-Raurell, Francisco Javier Sánchez-Chillón, Martín Torralba-Melero, Andrés Rojo-Rojo, Alfonso Muriel-García, Ana Carolina Amaya Arias, Juan Roldán-Merino and 1 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marta Raurell-TorredàDepartment of Fundamental and Clinical Care Nursing, Hospitalet del Llobregat, Universitat de Barcelona, Campus de Bellvitge, Barcelona, Spain.
Ignacio Zaragoza-GarcíaSimulation Group of the Spanish Society for Intensive Care and Coronary Unit Nursing (SEEIUC), Madrid, Spain.ORCID 0000-0002-8606-1415
Oscar ArroganteSimulation Group of the Spanish Society for Intensive Care and Coronary Unit Nursing (SEEIUC), Madrid, Spain.ORCID 0000-0001-8304-9093
Anna María Aliberch-RaurellSimulation Group of the Spanish Society for Intensive Care and Coronary Unit Nursing (SEEIUC), Madrid, Spain.
Francisco Javier Sánchez-ChillónSimulation Group of the Spanish Society for Intensive Care and Coronary Unit Nursing (SEEIUC), Madrid, Spain.
Martín Torralba-MeleroSimulation Group of the Spanish Society for Intensive Care and Coronary Unit Nursing (SEEIUC), Madrid, Spain.ORCID 0000-0001-5769-4486
Andrés Rojo-RojoSimulation Group of the Spanish Society for Intensive Care and Coronary Unit Nursing (SEEIUC), Madrid, Spain.ORCID 0000-0001-8409-1744
Alfonso Muriel-GarcíaBiostatistics Unit, Department of Nursing and Physiotherapy, Hospital Universitario Ramón y Cajal, IRYCIS, CIBERESP, Universidad de Alcalá, Madrid, Spain.
Ana Carolina Amaya AriasDivision of Non-Communicable Diseases, Ministry of Health and Social Protection, Bogotá, Colombia.
Juan Roldán-MerinoMental Health, Psychosocial and Complex Nursing Care Research Group-2021 SGR 01083, Spain.
Mariona Farrés-TarafaDepartment of Fundamental and Clinical Care Nursing, Hospitalet del Llobregat, Universitat de Barcelona, Campus de Bellvitge, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo analyse the interrater reliability of the NEUMOBACT checklist and verify whether consistent results are reproducible.

methodsA validation study with a cross-sectional design, compliant with the GRRAS checklist, among ICU nurses attending a SIMULAZERO course with an Objective Structured Clinical Evaluation simulation format, to verify transfer from theory to clinical practice of knowledge and skills in ventilator-associated pneumonia (VAP) and catheter-related bacteraemia (CRB) prevention. A minimum sample size of 111 pairs of nurse raters was calculated. Interrater agreement was analysed using Gwet's AC1 for each item and as a total for each of the three checklists in the NEUMOBACT instrument.

resultsA total of 95 pairs of valid NEUMOBACT checklists were completed by 190 raters with a median age of 29 [25-35] years, 93.7% were female. At the Central Venous Catheter insertion station, Gwet's AC1 was 0.934 (95% CI [0.919-0.949]). Only 2 of the 17 items scored below 0.9. At the Endotracheal Suctioning station, Gwet's AC1 was 0.869 (95% CI [0.851-0.886]). Of the 26 items that made up this station, 16 had an agreement percentage above 0.9, a further 9 were between 0.821 and 0.884, and item 13 had a value of 0.789. At the Patient Care station, Gwet's AC1 was 0.911 (95% CI [0.896-0.927]). Of the 21 items, 17 showed an agreement percentage above 0.9 and 4 were between 0.810 and 0.894.

conclusionsThe interrater reliability of the NEUMOBACT checklist shows substantial agreement between pairs of raters and is therefore validated in this large sample of ICU nurses. RELEVANCE TO CLINICAL PRACTICE: The NEUMOBACT checklist can be useful for assessing skills before and after training in VAP and CRB prevention measures and during debriefing (post-simulation feedback), to reinforce the scientific evidence behind actions and decisions for items that have been performed incorrectly, thus consolidating training already received.

Indexed as

ChecklistPneumonia, Ventilator-AssociatedAdultBacteremiaCatheter-Related InfectionsClinical CompetenceCritical Care NursingCross-Sectional StudiesFemaleHumansIntensive Care UnitsMaleNursesObserver VariationReproducibility of Results

Identifiers

PMID39739706
PMCPMC11687784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.